95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
REVIEW article
Front. Clin. Diabetes Healthc.
Sec. Diabetes Health Services and Health Economics
Volume 6 - 2025 | doi: 10.3389/fcdhc.2025.1495849
This article is part of the Research Topic Diabetes Care Reform: Improve Health and Health Equity View all 4 articles
Perspectives of Type 2 Diabetes Mellitus Management in Algeria: A comprehensive expert review
Provisionally accepted
Mohamed Belhadj 1
Rachid Malek 2
Houssem Baghous 3 Mourad Boukheloua 4 Zakia Arbouche 5 Nassim Nouri 6 Mohammed El Amine Amani 1
Fethia Sersoub 7*
Mohamed Amine Haireche 8,9*- 1 Internal Medicine Department, Specialist Hospital 1er Novembre 1954, Oran, Algeria
- 2 Internal Medicine Department, University Ferhat Abbas of Setif, Sétif, Sétif, Algeria
- 3 Department of Diabetology, Mustapha Bacha University Hospital, Algiers, Algeria
- 4 Department of Cardiology, Nafissa Hamoud University Hospital (ex Parnet), Algiers, Algeria
- 5 Private Clinic, Algiers, Algeria
- 6 Faculty of Medicine of Constantine, Constantine, Algeria
- 7 Hikma Pharmaceuticals, Algiers, Algeria
- 8 Medical Axès, Boulogne Billancourt, France
- 9 Scientia Vallis, Paris, France
Type 2 diabetes mellitus (T2DM) has become a pandemic, posing a significant burden on healthcare systems worldwide, notably in developing countries. This comprehensive review provides an in-depth assessment of the T2DM situation in Algeria, to understand its multifaceted burden and identify priority areas of action. A comprehensive literature search encompassed published articles on T2DM in Algeria conducted and analyzed by a diabetes expert committee. Epidemiological data point towards a constant rise of T2DM prevalence, roughly from 8.9% in 2003 to 14.4% in 2016-2017. The mean onset of T2DM is around 41 years, with older age associated with a higher risk and women experiencing a greater burden at younger age. Low socioeconomic status, limited education, and lack of health insurance exacerbate T2DM risk and health inequities. Obesity and lifestyle factors are prevalent, along with metabolic risk factors. Despite advancements in glycemic control, prescribing practices lack standardization, with suboptimal use of antidiabetic drugs and an absence of novel drugs in the market. Health and economic burdens are dominated by complications, highlighting inadequate prevention strategies. This review underscores the necessity for a comprehensive strategy including enhanced prevention, access to novel treatments, standardized practices, along with a patient-centered approach.
Keywords: type 2 diabetes mellitus, Algeria, Burden, Socioeconomic Factors, prevention, Management strategy
Received: 13 Sep 2024; Accepted: 28 Feb 2025.
Copyright: © 2025 Belhadj, Malek, Baghous, Boukheloua, Arbouche, Nouri, Amani, Sersoub and Haireche. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Fethia Sersoub, Hikma Pharmaceuticals, Algiers, Algeria
Mohamed Amine Haireche, Medical Axès, Boulogne Billancourt, France
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.